A public health system in crisis
21 Apr, 2021 03:32 AM
14 minutes to read
Chris Leitch says the need for charity hospitals is an absolute disgrace. Photo / NZ Herald
Northland Age
HEADLINE: A public health system in crisis
Responsibility for the greatest health crisis the country has faced since tuberculosis was a major killer of Pākeha New Zealanders, accounting for 10 per cent of all deaths in the late 19th Century, can be laid firmly at the revolving door of continual changes to the administration of the health system.
Back then Māori were even more vulnerable, with their tuberculosis death rates around ten times those of non-Māori by the 1930s. Re-arranging the deckchairs on the Titanic, as proposed by the Simpson report, will not change those relative inequities of outcome that remain today, or provide more resources to alleviate the critical state of the country s emergency departments.
Published:
6:00 PM April 6, 2021
At the Gresham s School Dyson Building topping out ceremony were, from left, Robert Dale from Daniel Connal Partnership; Douglas Robb, Gresham’s headmaster; Dennis Cotton from Kier; Michael Goff, Gresham’s chairman of governors and Michele Manzella from Wilkinson Eyre.
- Credit: Kier
Beer was poured onto the roof of a new science and technology building at Gresham s School in a traditional topping out ceremony.
The bottles of Moon Gazer Jigfoot produced by the Norfolk Brewhouse were used to mark the milestone on the project, which former pupil and Britain s richest man Sir James Dyson funded through a £19 million gift.
30 January 2021 • 12:01am
Stella Kyriakides, the EU s health commissioner, who said of AstraZeneca s vaccine supply: We reject the logic of first come, first served. That might work at the neighbourhood butchers but not on our contracts
Credit: Johanna Geron /Reuters
SIR – Reading between the lines, it looks as though the AstraZeneca plant in Belgium is having scale-up problems. Hence its “best efforts” fall well short of the EU’s belated order.
With our astounding success at securing supplies of vaccines, why don’t we offer to divert any excess UK-made supplies to the EU – provided it cuts the unnecessary bureaucracy on our exports?